16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social...read more
Miromatrix Medical, a developing novel bioengineering technology for organ transplants, raised $43 million by offering 4.8 million shares at $9, the high end of the range of $7 to $9. The company offered 0.8 million more shares than anticipated. Miromatrix is...read more
Updated Monday, 6/21/21. 17 IPOs are scheduled to raise $6.3 billion in the week ahead, led by two billion-dollar deals. Chinese freight platform Full Truck Alliance (YMM) plans to raise $1.5 billion at a $19.7 billion market cap....read more
Miromatrix Medical, which is developing novel bioengineering technology for organ transplants, announced terms for its IPO on Wednesday.
The Eden Prairie, MN-based company plans to raise $32 million by offering 4 million shares at a price range of $7 to $9....read more
US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week
16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social...read more
Organ bioengineering company Miromatrix Medical prices upsized IPO at $9 high end
Miromatrix Medical, a developing novel bioengineering technology for organ transplants, raised $43 million by offering 4.8 million shares at $9, the high end of the range of $7 to $9. The company offered 0.8 million more shares than anticipated. Miromatrix is...read more
US IPO Week Ahead: Billion-dollar deals come to market in a 17 IPO week
Updated Monday, 6/21/21. 17 IPOs are scheduled to raise $6.3 billion in the week ahead, led by two billion-dollar deals. Chinese freight platform Full Truck Alliance (YMM) plans to raise $1.5 billion at a $19.7 billion market cap....read more
Organ bioengineering company Miromatrix Medical sets terms for $32 million IPO
Miromatrix Medical, which is developing novel bioengineering technology for organ transplants, announced terms for its IPO on Wednesday. The Eden Prairie, MN-based company plans to raise $32 million by offering 4 million shares at a price range of $7 to $9....read more